OMERS Administration Corp’s Bristol-Myers Squibb BMY Stock Holding History

OMERS Administration Corp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.99M	Buy	173,350 +17,903	+12%	+$1.03M	0.06%	195
2026 Q1	$9.43M	Buy	155,447 +30,934	+25%	+$1.8M	0.06%	147
2025 Q4	$6.72M	Buy	124,513 +802	+0.6%	+$38.6K	0.05%	154
2025 Q3	$5.58M	Buy	123,711 +100	+0.1%	+$4.67K	0.04%	173
2025 Q2	$5.72M	Buy	123,611 +10,900	+10%	+$535K	0.05%	154
2025 Q1	$6.87M	Buy	112,711 +818	+0.7%	+$47.7K	0.06%	132
2024 Q4	$6.33M	Sell	111,893 -2,409	-2%	-$135K	0.06%	142
2024 Q3	$5.91M	Buy	114,302 +34,900	+44%	+$1.64M	0.05%	146
2024 Q2	$3.3M	Buy	+79,402	New	+$3.55M	0.03%	227
2020 Q1	–	Sell	-198,900	Closed	-$12.8M	–	208
2019 Q4	$12.8M	Sell	198,900 -33,100	-14%	-$1.9M	0.15%	71
2019 Q3	$11.8M	Buy	232,000 +48,900	+27%	+$2.3M	0.12%	83
2019 Q2	$8.42M	Buy	183,100 +151,400	+478%	+$7.05M	0.09%	107
2019 Q1	$1.57M	Buy	+31,700	New	+$1.58M	0.02%	169
2018 Q4	–	Sell	-149,100	Closed	-$9.26M	–	174
2018 Q3	$9.26M	Sell	149,100 -14,900	-9%	-$884K	0.09%	75
2018 Q2	$9.08M	Buy	164,000 +71,700	+78%	+$3.87M	0.08%	72
2018 Q1	$5.84M	Buy	+92,300	New	+$5.94M	0.06%	146

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OMERS Administration Corp's BMY Position: Q2 2026 in Review

OMERS Administration Corp increased its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, buying an estimated $1.03M and bringing the position to 173,350 shares worth $9.99M. The position accounts for 0.06% of the portfolio, ranked #195.

OMERS Administration Corp first reported a position in BMY in Q1 2018 and has held it in 16 quarters since. The position peaked at $12.8M in Q4 2019. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

OMERS Administration Corp held 173,350 shares of Bristol-Myers Squibb worth $9.99M as of Q2 2026.
OMERS Administration Corp bought 17,903 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.03M.
Bristol-Myers Squibb made up 0.06% of OMERS Administration Corp's portfolio in Q2 2026, its #195 holding.
OMERS Administration Corp first reported a position in Bristol-Myers Squibb in Q1 2018 and has held it in 16 quarters since.
OMERS Administration Corp's Bristol-Myers Squibb position peaked at $12.8M in Q4 2019.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.